---
output: 
  md_document:
    variant: gfm  # GitHub-flavored Markdown (for better rendering on GitHub)
    preserve_yaml: true  # Keep YAML metadata in the output
params:
  trial: ''
---

**NCT06112379**

<div style="padding: 5px 5px 5px 0px; font-size: 1.20em; font-weight: 500; color: #2E4A7F; text-align: left; margin-bottom: 20px">

(TROPION-Breast04) Estudo de Fase III comparando Dato-DXd neoadjuvante
mais durvalumab versus pembrolizumab mais quimioterapia em pacientes com
câncer de mama TNBC ou receptor hormonal baixo/HER2-negativo não
tratados.

</div>

**Título Oficial:** A Phase III, Open-label, Randomised Study of
Neoadjuvant Datopotamab Deruxtecan (Dato-DXd) Plus Durvalumab Followed
by Adjuvant Durvalumab With or Without Chemotherapy Versus Neoadjuvant
Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab With
or Without Chemotherapy for the Treatment of Adult Patients With
Previously Untreated Triple-Negative or Hormone
Receptor-low/HER2-negative Breast Cancer (D926QC00001; TROPION-Breast04)

**Desenho do Estudo:** Estudo Clinico Fase III

**Resumo do Estudo:** Este estudo de Fase III avalia a eficácia e
segurança do Datopotamab Deruxtecan (Dato-DXd) neoadjuvante mais
durvalumab seguido de durvalumab adjuvante, com ou sem quimioterapia, em
comparação com pembrolizumab neoadjuvante mais quimioterapia seguido de
pembrolizumab adjuvante, com ou sem quimioterapia. A população-alvo
inclui pacientes adultos com câncer de mama triplo-negativo (TNBC) não
tratado anteriormente ou câncer de mama com receptor hormonal
baixo/HER2-negativo. O estudo é conduzido globalmente em vários centros
e visa determinar o regime de tratamento mais eficaz para esses subtipos
específicos de câncer de mama.

**Paciente Ideal:** Este estudo de Fase III avalia a eficácia e
segurança do Datopotamab Deruxtecan (Dato-DXd) neoadjuvante mais
durvalumab seguido de durvalumab adjuvante, com ou sem quimioterapia, em
comparação com pembrolizumab neoadjuvante mais quimioterapia seguido de
pembrolizumab adjuvante, com ou sem quimioterapia. A população-alvo
inclui pacientes adultos com câncer de mama triplo-negativo (TNBC) não
tratado anteriormente ou câncer de mama com receptor hormonal
baixo/HER2-negativo. O estudo é conduzido globalmente em vários centros
e visa determinar o regime de tratamento mais eficaz para esses subtipos
específicos de câncer de mama.

Para mais informações, acesse as informações do estudo no
*clinicaltrials.gov* no seguinte
[link](https://clinicaltrials.gov/ct2/show/NCT06112379)

**Centros Participantes**

Se você conhece algum centro participante que não esteja listado, clique
em
<span style="color: #2E4A7F; margin-left: 2px; padding: 4px; background-color: #f3f2f1; border-radius: 8px; font-weight: 500; font-size: 0.7em"><a
href="https://flazar.shinyapps.io/formsapp?study_nct_id=NCT06112379&amp;location_id=N%2FA&amp;location_full_name=N%2FA&amp;form_type=Adicionar%20Centro"
target="_blank">ADICIONAR CENTRO</a></span>.

<div style="margin-bottom: 8px; margin-left: 5px; padding: 8px; max-width: 300px; background-color: #f3f2f1; border-radius: 8px; font-size: 0.8em">

<div style="margin-left: 10px;">

    <span 
      style="border: 0.5px solid black; background-color: #9fd89f; width: 15px; height: 15px; display: inline-block; margin-right: 5px; border-radius: 50%;"></span>
    <p style="display: inline;">Recrutamento Ativo</p>

</div>

<div style="margin-left: 10px;">

    <span 
      style="border: 0.5px solid black; background-color: #fef7b2; width: 15px; height: 15px; display: inline-block; margin-right: 5px; border-radius: 50%;"></span>
    <p style="display: inline;">Ainda Não Recrutando</p>

</div>

<div style="margin-left: 10px;">

    <span 
      style="border: 0.5px solid black; background-color: #f4bfab; width: 15px; height: 15px; display: inline-block; margin-right: 5px; border-radius: 50%;"></span>
    <p style="display: inline;">Recrutamento Suspenso/Encerrado</p>

</div>

</div>

<span style="border: 0.5px solid black; display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: #9fd89f;"></span>
CE CRIO-Centro Regional Integrado de Oncologia 60335-480, Fortaleza
<span style="color: #2E4A7F; margin-left: 2px; padding: 4px; background-color: #f3f2f1; border-radius: 8px; font-weight: 500; font-size: 0.7em">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT06112379&location_id=RESEARCHSITEFORTALEZA60336045BRAZIL&location_full_name=CRIO-Centro%20Regional%20Integrado%20de%20Oncologia%2C%2060335-480%2C%20Fortaleza&form_type=Reportar%20Erro)\_blank}</span>

<span style="border: 0.5px solid black; display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: #9fd89f;"></span>
DF Hospital Brasília 71681-603, Brasília
<span style="color: #2E4A7F; margin-left: 2px; padding: 4px; background-color: #f3f2f1; border-radius: 8px; font-weight: 500; font-size: 0.7em">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT06112379&location_id=RESEARCHSITEBRASILIA71681603BRAZIL&location_full_name=Hospital%20Bras%C3%ADlia%2C%2071681-603%2C%20Bras%C3%ADlia&form_type=Reportar%20Erro)\_blank}</span>

<span style="border: 0.5px solid black; display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: #9fd89f;"></span>
ES Hospital Santa Rita 29043-260, Vitória
<span style="color: #2E4A7F; margin-left: 2px; padding: 4px; background-color: #f3f2f1; border-radius: 8px; font-weight: 500; font-size: 0.7em">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT06112379&location_id=RESEARCHSITEVITORIA29043260BRAZIL&location_full_name=Hospital%20Santa%20Rita%2C%2029043-260%2C%20Vit%C3%B3ria&form_type=Reportar%20Erro)\_blank}</span>

<span style="border: 0.5px solid black; display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: #9fd89f;"></span>
PR Hospital do Câncer de Londrina 86015-520, Londrina
<span style="color: #2E4A7F; margin-left: 2px; padding: 4px; background-color: #f3f2f1; border-radius: 8px; font-weight: 500; font-size: 0.7em">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT06112379&location_id=RESEARCHSITELONDRINA86015520BRAZIL&location_full_name=Hospital%20do%20C%C3%A2ncer%20de%20Londrina%2C%2086015-520%2C%20Londrina&form_type=Reportar%20Erro)\_blank}</span>

<span style="border: 0.5px solid black; display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: #9fd89f;"></span>
RN Centro Avançado de Oncologia (CECAN) 59062-000, Natal
<span style="color: #2E4A7F; margin-left: 2px; padding: 4px; background-color: #f3f2f1; border-radius: 8px; font-weight: 500; font-size: 0.7em">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT06112379&location_id=RESEARCHSITENATAL59075740BRAZIL&location_full_name=Centro%20Avan%C3%A7ado%20de%20Oncologia%20%28CECAN%29%2C%2059062-000%2C%20Natal&form_type=Reportar%20Erro)\_blank}</span>

<span style="border: 0.5px solid black; display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: #9fd89f;"></span>
RS Centro de Pesquisa Clínica - HCPA 90035-007, Porto Alegre
<span style="color: #2E4A7F; margin-left: 2px; padding: 4px; background-color: #f3f2f1; border-radius: 8px; font-weight: 500; font-size: 0.7em">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT06112379&location_id=RESEARCHSITEPORTOALEGRE90035000BRAZIL&location_full_name=Centro%20de%20Pesquisa%20Cl%C3%ADnica%20-%20HCPA%2C%2090035-007%2C%20Porto%20Alegre&form_type=Reportar%20Erro)\_blank}</span>

<span style="border: 0.5px solid black; display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: #9fd89f;"></span>
RS Hospital de Clínicas de Porto Alegre 90035-903, Porto Alegre
<span style="color: #2E4A7F; margin-left: 2px; padding: 4px; background-color: #f3f2f1; border-radius: 8px; font-weight: 500; font-size: 0.7em">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT06112379&location_id=RESEARCHSITEPORTOALEGRE90035903BRAZIL&location_full_name=Hospital%20de%20Cl%C3%ADnicas%20de%20Porto%20Alegre%2C%2090035-903%2C%20Porto%20Alegre&form_type=Reportar%20Erro)\_blank}</span>

<span style="border: 0.5px solid black; display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: #9fd89f;"></span>
SP CEPHO - Centro de Estudos e Pesquisa de Hematologia 09060-650, Santo
André
<span style="color: #2E4A7F; margin-left: 2px; padding: 4px; background-color: #f3f2f1; border-radius: 8px; font-weight: 500; font-size: 0.7em">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT06112379&location_id=RESEARCHSITESANTOANDRE09060650BRAZIL&location_full_name=CEPHO%20-%20Centro%20de%20Estudos%20e%20Pesquisa%20de%20Hematologia%2C%2009060-650%2C%20Santo%20Andr%C3%A9&form_type=Reportar%20Erro)\_blank}</span>

<span style="border: 0.5px solid black; display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: #9fd89f;"></span>
SP Instituto do Câncer do Estado de São Paulo - ICESP Unidade São Paulo
01246-000, São Paulo
<span style="color: #2E4A7F; margin-left: 2px; padding: 4px; background-color: #f3f2f1; border-radius: 8px; font-weight: 500; font-size: 0.7em">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT06112379&location_id=RESEARCHSITESAOPAULO01246000BRAZIL&location_full_name=Instituto%20do%20C%C3%A2ncer%20do%20Estado%20de%20S%C3%A3o%20Paulo%20-%20ICESP%20Unidade%20S%C3%A3o%20Paulo%2C%2001246-000%2C%20S%C3%A3o%20Paulo&form_type=Reportar%20Erro)\_blank}</span>

<span style="border: 0.5px solid black; display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: #9fd89f;"></span>
SP Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto
14015-010, Ribeirão Preto
<span style="color: #2E4A7F; margin-left: 2px; padding: 4px; background-color: #f3f2f1; border-radius: 8px; font-weight: 500; font-size: 0.7em">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT06112379&location_id=RESEARCHSITERIBEIRAOPRETO14051140BRAZIL&location_full_name=Hospital%20das%20Cl%C3%ADnicas%20da%20Faculdade%20de%20Medicina%20de%20Ribeir%C3%A3o%20Preto%2C%2014015-010%2C%20Ribeir%C3%A3o%20Preto&form_type=Reportar%20Erro)\_blank}</span>

<span style="border: 0.5px solid black; display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: #fef7b2;"></span>
SP ICB - Instituto do Câncer Brasil \| Unidade Taubaté \| Oncologista em
Taubaté 12030-200, Taubaté
<span style="color: #2E4A7F; margin-left: 2px; padding: 4px; background-color: #f3f2f1; border-radius: 8px; font-weight: 500; font-size: 0.7em">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT06112379&location_id=RESEARCHSITETAUBATE12030200BRAZIL&location_full_name=ICB%20-%20Instituto%20do%20C%C3%A2ncer%20Brasil%20%7C%20Unidade%20Taubat%C3%A9%20%7C%20Oncologista%20em%20Taubat%C3%A9%2C%2012030-200%2C%20Taubat%C3%A9&form_type=Reportar%20Erro)\_blank}</span>

<span style="border: 0.5px solid black; display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: #fef7b2;"></span>
PR Oncologia D’Or Hospital Santa Cruz 80440-220, Curitiba
<span style="color: #2E4A7F; margin-left: 2px; padding: 4px; background-color: #f3f2f1; border-radius: 8px; font-weight: 500; font-size: 0.7em">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT06112379&location_id=RESEARCHSITECURITIBA80440220BRAZIL&location_full_name=Oncologia%20D%E2%80%99Or%20Hospital%20Santa%20Cruz%2C%2080440-220%2C%20Curitiba&form_type=Reportar%20Erro)\_blank}</span>
